All lobbying filings

Arnold & Porter Kaye Scholer LLP

Arnold & Porter Kaye Scholer LLP filed a Q2 report for Recordati Rare Diseases Inc. on July 17, 2026, reporting $60,000 in lobbying income.

Lobbying for Recordati Rare Diseases Inc. · Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.

As filed: ARNOLD & PORTER KAYE SCHOLER LLP for RECORDATI RARE DISEASES INC.

All filings by Arnold & Porter Kaye Scholer LLP · Everything Recordati Rare Diseases Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 17, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbying activity 3

Medicare/Medicaid

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Health Issues

Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.

Trade (domestic/foreign)

Issues related to trade and tariff policies pertaining to therapies for rare and ultra-rare diseases in the United States.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.